Chemical Properties:
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.Manufacturer with High Purity and Stable Quality Chemical Name: Orlistat CAS: 96829-58-2 API High Quality, Commercial Production| Item | Specifications |
| Appearance | White or Almost White Crystalline Powder |
| Identification | HPLC |
| Purity / Analysis Method | ≥98.0% (HPLC) |
| Specific Rotation | -33.0° ~ -35.0° |
| Acidity | 6.0~8.0 |
| Melting Point | 43.0℃~48.0℃ |
| Moisture (K.F) | ≤0.50% |
| Max Individual Impurity | ≤0.50% |
| Total Impurities | ≤2.0% |
| Residual Sovents n-Hexane | ≤290ppm |
| Residual Sovents n-Heptane | ≤5000ppm |
| Residue on Ignition | ≤0.20% |
| Arsenic | ≤1ppm |
| Chloride | ≤0.05% |
| Iron | ≤0.01% |
| Heavy Metals | ≤10ppm |
| Test Standard | Chinese Pharmacopoeia; Enterprise Standard |
| Usage | Active Pharmaceutical Ingredient (API) |
Description:
Specifications:
Package & Storage:
| Chemical Name | Orlistat |
| CAS Number | 96829-58-2 |
| CAT Number | RF-API11 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C29H53NO5 |
| Molecular Weight | 495.73 |
| Solubility | Soluble in Water |
| Shipping Condition | Under Ambient Temperature |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Orlistat is an internationally recognized new form of weight loss drug. Its commercial name is Sainike and first went on sale in New Zealand in 1998. Orlistat is a long-term and highly effective specific gastrointestinal lipase inhibitor, and it is insoluble in water, soluble in chloroform, and easily soluble in ethanol. Orlistat can be used clinically to treat obesity. Usually, a dose of 120mg is taken three times a day within one hour of a meal. Weight loss begins to occur after two weeks of usage. It can be used continuously for 6-12 months, and its effects will cease to increase after daily dosage exceeds 400mg. This drug is suitable to be used in combination with a low-calorie diet by obese and overweight individuals, and it can also be used as long-term treatment for patients who have faced weight-related risk factors. Orlistat has a long-term weight-control effect that reduces and maintains weight and prevents against rebounding. Using Orlistat can lower the occurrences of weight-related risk factors and diseases, including hypercholesterolemia, type-2 diabetes, impaired glucose tolerance, hyperinsulinemia, and hypertension, and it can reduce the fat content in organs. Orlistat also adjusts blood lipid levels: it can decrease serum triglycerides (TG) and low density lipoprotein cholesterol (LDL-C), and it can increase the ratio of high density lipoproteins to low density lipoproteins in obese patients.
